Stocks
Alector, Inc.ALEC
NASDAQHealthcareBiotechnology$1.95
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing therapies for neurodegenerative diseases, including Alzheimer's and frontotemporal dementia. Its lead programs target the innate immune system's microglia pathway, with multiple candidates in Phase 2 and Phase 3 trials. Investors track ALEC for its potential to address large unmet needs in neurology and for its partnerships with major pharmaceutical companies.
52W Range: $1.09-$3.33
Congressional Interest in Alector, Inc. (ALEC)
No congressional trades have been disclosed for Alector, Inc. (ALEC) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading ALEC?
No congressional trades found for this stock.